Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Tolcapone MeSH Descriptor Data 2025


MeSH Heading
Tolcapone
Tree Number(s)
D02.455.426.559.389.134.875
D02.455.426.559.389.657.566.845
D02.522.223.875
D02.640.743.845
Unique ID
D000077867
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077867
Scope Note
A benzophenone and nitrophenol compound that acts as an inhibitor of CATECHOL O-METHYLTRANSFERASE, an enzyme involved in the metabolism of DOPAMINE and LEVODOPA. It is used in the treatment of PARKINSON DISEASE in patients for whom levodopa is ineffective or contraindicated.
Entry Term(s)
3,4-Dihydroxy-5'-methyl-5-nitrobenzophenone
Ro 40-7592
Ro-40-7592
SOM0226
Tasmar
Pharm Action
Antiparkinson Agents
Catechol O-Methyltransferase Inhibitors
Registry Numbers
CIF6334OLY
0
Related Numbers
134308-13-7
CAS Type 1 Name
Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-
Public MeSH Note
2019; TOLCAPONE was indexed under BENZOPHENONES and NITROPHENOLS 1990-2018
History Note
2019 (1990)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/05/21
Tolcapone Preferred
Ro 40-7592 Narrower
Tasmar Narrower
SOM0226 Narrower
3,4-Dihydroxy-5'-methyl-5-nitrobenzophenone Related
page delivered in 0.149s